Global Anti Infective Drugs Market
Anti-Infective Drugs Market Size And Forecast
According to Verified Market Research, Global Anti-Infective Drugs Market was valued at USD 84.07 Billion in 2018 and is projected to reach USD 141.8 Billion by 2026, growing at a CAGR of 6.7% from 2019 to 2026.
Global Anti-Infective Drugs Market Outlook
The growing burden of several infectious diseases across the developed and emerging markets such as different types of influenza, diarrhea, hepatitis, and urinary tract infections, that requires the more attention from pharmaceutical and biotechnological companies. This, in turn, the primary factor for the growth of the global anti-infective drug market. The development of new multi-drug resistance against micro-organisms is another factor further expected to fuel the growth of the market. However, high investment costs in research and development and shortage of resources in healthcare facilities are the factors that might restrict the market growth.
Global Anti-Infective Drugs Market Competitive Landscape
The Global Anti-Infective Drugs Market study report will provide a valuable insight with an emphasis on global market including some of the major players such as Novartis, Merck & Co., Johnson & Johnson, GlaxoSmithKline plc, Gilead Sciences, Boehringer Ingelheim GmbH, Pfizer, Teva Pharmaceutical Industries Ltd., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd.
Verified Market Research has been providing Research Reports, with up to date information, and in-depth analysis, for several years now, to individuals and companies alike that are looking for accurate Research Data. It has large database which includes the latest content from renowned authors and publications worldwide. It also provides customized Data and Reports according to the need of the client.